BACKGROUND Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic
A lcoholic cardiomyopathy (ACM) is
caused by chronic and excessive alcohol intake (1) (2) (3) (4) . Although moderate levels of alcohol consumption may have some beneficial cardiovascular effects (3, 5) , prolonged and excessive consumption can lead to deleterious consequences including cardiac arrhythmias and a dilated cardiomyopathy (DCM) phenotype (2) (3) (4) (5) .
The pathophysiology of ACM is not fully understood, and the relationship between the degree of alcohol exposure and severity of endorgan damage is not simple (2, 6) . In particular, not all individuals with high alcohol intake develop ACM, and this heterogeneity in response indicates differences in underlying susceptibility, likely both genetic and environmental. However, studies of heritable contributors to ACM are currently limited (7, 8) . Prognosis in ACM is poor, but is considered more favorable than DCM generally, with recovery observed in up to one-third of cases, especially when alcohol intake is reduced (3) . Current management of ACM individuals includes cessation of alcohol exposure, standard heart failure medications, and prevention of sudden cardiac death (2, 6, 9) . As the genetic contribution to ACM is currently unknown, familial evaluation is not part of ACM management.
DCM is estimated to affect up to 1 in 250 individuals (10) and has a significant genetic contribution, with truncation variants in the gene encoding titin (TTNtv), a key sarcomeric protein, representing the predominant genetic cause, seen in 10% to 20% of cases (11) (12) (13) . It is also recognized that up to 1% of the general population carry a TTNtv, presenting a significant challenge to interpretation (12) . Genetic and/or environmental factors likely underlie the variable penetrance and expressivity. In line with this, recent evidence has shown that over 10% of patients with peripartum cardiomyopathy carry a TTNtv, suggesting that in some patients, the DCM phenotype results from a combination of pregnancy with a genetic predisposing background (14) .
Moreover, we have recently demonstrated that TTNtv found in the general population are not phenotypically silent (15) ; although the population prevalence of TTNtv exceeds the prevalence of DCM, careful phenotyping reveals differences in cardiac volumes in subjects with and without TTNtv. Using a rat model, we found essentially normal resting cardiac function, but subclinical metabolic abnormalities in TTNtv carriers and impaired cardiac physiology under conditions of cardiac stress (15) . Together, these data suggest that TTNtv may predispose to cardiomyopathy, with environmental factors modulating penetrance and expressivity.
Here, we sought to evaluate genetic determinants in the pathophysiology of ACM by characterizing genetic variation in known DCM-causing genes in a large ACM cohort. We sequenced 141 individuals with ACM and compared these with healthy volunteers European Reference Network for rare, low-prevalence, and complex diseases of the heart (ERN GUARD-Heart). The funders played no role in the design, collection, analysis, or interpretation of the data or in the decision to submit the manuscript for publication.
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In the case of titin, analysis was further restricted to truncating variants in exons constitutively expressed in the heart as described (12) . Although the Illumina TruSight Cardio sequencing kit captures 61 genes purportedly associated with DCM (full gene list and variants detected are given in Online Table 7) , we decided to be conservative and pre-specified a focused analysis on 9 genes with the most robust Values are mean AE SD or n (%).
ACM ¼ alcoholic cardiomyopathy; CMR ¼ cardiac magnetic resonance; DCM ¼ dilated cardiomyopathy.
ExAC reference samples, for either truncating or nontruncating variants (13, 21) . Computing, Vienna, Austria). All data and code required to reproduce these analyses are available online (24) .
EVALUATION OF ALCOHOL AS

RESULTS
GENETIC CONTRIBUTION TO ACM. To investigate the potential genetic contribution of cardiomyopathy Table 2 ). TTNtv accounted for the majority of variants detected in ACM cases (9.9%) and were found with a frequency similar to that seen in DCM There were no detectable differences in phenotype or demographics between ACM cases with and without TTNtv ( TTNtv ¼ titin truncating variant; other abbreviations as in Table 1 . showing LVEF recovery irrespective of TTNtv status (Table 3) , and no detectable difference in event-free survival between the 2 groups ( Figure 1 ).
ALCOHOL AS A PHENOTYPIC MODIFIER IN DCM.
Having established a genetic contribution to ACM in a proportion of cases, primarily driven by TTNtv, we These individuals were more likely to be male, and in univariate analyses had modestly reduced LVEF Table 5 ). A total of 83 DCM cases carried a TTNtv We further identified a direct interaction between
TTNtv and alcohol consumption in the context of The overall effect of alcohol on the occurrence of DCM is also difficult to assess, but previous reports have suggested that it may be involved in as many as 47% of cases (6), and a recent population-based study
CENTRAL ILLUSTRATION Alcohol Consumption and Genetic Background Act in Concert to
Determine Cardiac Phenotype
Prevalence of rare genetic variants in cardiomyopathy genes:
LVEF according to titin truncating variant (TTNtv) status and alcohol intake:
Alcoholic Cardiomyopathy (ACM)
PHENOTYPE
Dilated Cardiomyopathy (DCM)
ACM: 13.5% Controls: 2.9% no TTNtv or excess alcohol intake: 39.6 ± 12.2%
TTNtv only: 39.8 ± 13.2% excess alcohol intake only: 37.8 ± 11.8% TTNtv AND excess alcohol intake: 27.7 ± 12.7% P Fisher = 0.000012 Red asterisks indicate cases with documented prolonged heavy alcohol consumption. CTx ¼ cardiac transplant; DCM ¼ dilated cardiomyopathy; MI ¼ myocardial infarction; SCA ¼ sudden cardiac arrest; VHD ¼ valvular heart disease; other abbreviations as in Figure 1 . 
